BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21141515)

  • 1. [Inulicin inhibits activation and expression of vascular remodeling enzymes induced by de-endothelium].
    Li JJ; Wen JK; Han M
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 May; 24(2):156-60. PubMed ID: 21141515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
    Mountain DJ; Freeman MB; Kirkpatrick SS; Cook RB; Chalk JE; Stevens SL; Goldman MH; Grandas OH
    Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression.
    Cheng XW; Kuzuya M; Sasaki T; Kanda S; Tamaya-Mori N; Koike T; Maeda K; Nishitani E; Iguchi A
    Cardiovasc Res; 2004 Jun; 62(3):594-602. PubMed ID: 15158152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIMP-2 modulates neointimal formation in experimental ePTFE arterial grafts.
    Cavallaro G; Cucina A; Randone B; Polistena A; Mosiello G; Coluccia P; De Toma G; Cavallaro A
    J Surg Res; 2007 Jan; 137(1):122-9. PubMed ID: 17070550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity.
    Pross C; Farooq MM; Angle N; Lane JS; Cerveira JJ; Xavier AE; Freischlag JA; Law RE; Gelabert HA
    J Surg Res; 2002 Feb; 102(2):57-62. PubMed ID: 11795999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.
    Hlawaty H; Suffee N; Sutton A; Oudar O; Haddad O; Ollivier V; Laguillier-Morizot C; Gattegno L; Letourneur D; Charnaux N
    Biochem Pharmacol; 2011 Jan; 81(2):233-43. PubMed ID: 20887714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
    Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
    Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of MMP-2,9 and TIMP-1 expressions in rats with pulmonary arterial hypertension after captopril and losartan interventions].
    Wang XM; Zhou TF; Liu B; Wei L; Shi K; Zhao SS; Hua YM; Liu HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):255-9. PubMed ID: 19462901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Co-overexpression of human tissue kallikrein 1 and human metalloproteinase 1 tissue inhibitor inhibits neointima formation in the rat artery after balloon angioplasty].
    Yu HZ; Zhang F; Zhu PL; Pan W; Huang SJ; Xiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 May; 44(5):436-42. PubMed ID: 27220581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9.
    Chung AW; Rauniyar P; Luo H; Hsiang YN; van Breemen C; Okon EB
    J Vasc Surg; 2005 Oct; 42(4):747-56. PubMed ID: 16242564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen sulfide protects against vascular remodeling from endothelial damage.
    Vacek TP; Gillespie W; Tyagi N; Vacek JC; Tyagi SC
    Amino Acids; 2010 Nov; 39(5):1161-9. PubMed ID: 20352463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
    Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
    J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB; Li DG; Lu HM
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MT1-MMP evaluation in neointimal hyperplasia in the late follow-up after prosthesis implantation.
    Bruczko M; Gogiel T; WolaƄska M; Kowalewski R; Sobolewski K; Romanowicz L
    Int J Exp Pathol; 2019 Apr; 100(2):94-101. PubMed ID: 31058412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.